PLEKHN1 | Pleckstrin homology domain containing, family N member 1 | | | ![](/images/31742/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31742/73584_B_9_1_rna_selected_60x60.jpg) | Group enriched |
C1orf170 | Chromosome 1 open reading frame 170 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31711/142468_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
TNFRSF18 | Tumor necrosis factor receptor superfamily, member 18 | CD markers Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8025/24767_B_9_4_rna_selected_60x60.jpg) | Tissue enriched |
TNFRSF4 | Tumor necrosis factor receptor superfamily, member 4 | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16128/35585_A_8_5_rna_selected_60x60.jpg) | Mixed |
SDF4 | Stromal cell derived factor 4 | Plasma proteins Predicted secreted proteins
| | | ![](/images/15227/ihc_cell_selected_60x60.jpg) | ![](/images/11249/124471_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CPSF3L | Cleavage and polyadenylation specific factor 3-like | Plasma proteins
| | ![](/images/28379/if_selected_60x60.jpg) | | ![](/images/29025/63088_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
DVL1 | Dishevelled segment polarity protein 1 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/11538/ihc_cell_selected_60x60.jpg) | ![](/images/11538/28612_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MXRA8 | Matrix-remodelling associated 8 | Predicted membrane proteins
| | ![](/images/55780/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55780/129120_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | ![](/images/53137/124911_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
MRPL20 | Mitochondrial ribosomal protein L20 | Mitochondrial proteins Ribosomal proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47074/105504_B_9_6_rna_selected_60x60.jpg) | Expressed in all |
ANKRD65 | Ankyrin repeat domain 65 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65720/148191_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM88B | Transmembrane protein 88B | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65743/146370_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
CDK11A | Cyclin-dependent kinase 11A | Enzymes
| | | ![](/images/25061/ihc_cell_selected_60x60.jpg) | ![](/images/10467/24103_B_4_4_rna_selected_60x60.jpg) | Expressed in all |
C1orf222 | Chromosome 1 open reading frame 222 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29274/141705_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
GABRD | Gamma-aminobutyric acid (GABA) A receptor, delta | Disease related genes FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44371/151898_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | ![](/images/21851/if_selected_60x60.jpg) | | ![](/images/21851/49689_B_9_3_rna_selected_60x60.jpg) | Mixed |
RER1 | Retention in endoplasmic reticulum sorting receptor 1 | Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/37240/71889_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6480/142257_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
MEGF6 | Multiple EGF-like-domains 6 | Predicted secreted proteins
| | ![](/images/52129/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/52129/120413_B_7_4_rna_selected_60x60.jpg) | Tissue enhanced |
TP73 | Tumor protein p73 | Plasma proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/2514/142947_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC47 | Leucine rich repeat containing 47 | | | | ![](/images/8512/ihc_cell_selected_60x60.jpg) | ![](/images/8512/23349_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
KCNAB2 | Potassium voltage-gated channel, shaker-related subfamily, beta member 2 | Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1975/5195_A_1_8_rna_selected_60x60.jpg) | Expressed in all |
ACOT7 | Acyl-CoA thioesterase 7 | Enzymes Mitochondrial proteins
| | | | ![](/images/25735/56118_B_4_8_rna_selected_60x60.jpg) | Mixed |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39462/82908_B_4_4_rna_selected_60x60.jpg) | Tissue enhanced |
PARK7 | Parkinson protein 7 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | ![](/images/4190/if_selected_60x60.jpg) | | ![](/images/5870/15959_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/69394/150508_A_9_5_rna_selected_60x60.jpg) | Expressed in all |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | ![](/images/28550/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28550/63023_B_1_8_rna_selected_60x60.jpg) | Tissue enriched |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images/5440/if_selected_60x60.jpg) | | ![](/images/5440/20677_B_3_6_rna_selected_60x60.jpg) | Expressed in all |
PIK3CD | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44953/139744_B_8_1_rna_selected_60x60.jpg) | Mixed |
DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/25230/57939_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PEX14 | Peroxisomal biogenesis factor 14 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/49231/112053_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
TARDBP | TAR DNA binding protein | Disease related genes Plasma proteins
| | | | ![](/images/3703/10477_B_1_6_rna_selected_60x60.jpg) | Expressed in all |
EXOSC10 | Exosome component 10 | | | | ![](/images/28484/ihc_cell_selected_60x60.jpg) | ![](/images/28470/59735_B_7_5_rna_selected_60x60.jpg) | Expressed in all |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/44120/101925_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
C1orf167 | Chromosome 1 open reading frame 167 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39114/151335_B_8_2_rna_selected_60x60.jpg) | Group enriched |
NPPA | Natriuretic peptide A | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58269/133551_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
TNFRSF8 | Tumor necrosis factor receptor superfamily, member 8 | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/16/318_B_7_6_rna_selected_60x60.jpg) | Mixed |
DHRS3 | Dehydrogenase/reductase (SDR family) member 3 | Enzymes Predicted membrane proteins
| | ![](/images/10844/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10844/26858_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PDPN | Podoplanin | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/7534/ihc_cell_selected_60x60.jpg) | ![](/images/8376/24700_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
FHAD1 | Forkhead-associated (FHA) phosphopeptide binding domain 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54284/122605_B_3_5_rna_selected_60x60.jpg) | Group enriched |
EFHD2 | EF-hand domain family, member D2 | | | ![](/images/48961/if_selected_60x60.jpg) | | ![](/images/48961/111197_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46920/108847_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26443/57052_B_3_4_rna_selected_60x60.jpg) | Tissue enhanced |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/60282/ihc_cell_selected_60x60.jpg) | ![](/images/60282/134282_B_8_3_rna_selected_60x60.jpg) | Group enriched |
SPEN | Spen family transcriptional repressor | Cancer-related genes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/15825/39442_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
CROCC | Ciliary rootlet coiled-coil, rootletin | | | | ![](/images/21762/ihc_cell_selected_60x60.jpg) | ![](/images/21191/50009_A_3_1_rna_selected_60x60.jpg) | Expressed in all |
MFAP2 | Microfibrillar-associated protein 2 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/7354/18651_A_3_5_rna_selected_60x60.jpg) | Tissue enhanced |
SDHB | Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted secreted proteins
| | | ![](/images/2868/ihc_cell_selected_60x60.jpg) | ![](/images/68235/150580_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47735/138690_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PADI1 | Peptidyl arginine deiminase, type I | Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62294/148131_B_4_4_rna_selected_60x60.jpg) | Tissue enriched |